PENGARUH OBAT KUMUR TERHADAP KONDISI MUKOSITIS PASIEN KANKER RONGGA MULUT YANG MENERIMA KEMOTERAPI DAN RADIOTERAPI
Abstract
Introduction: Oral cancer, also known as mouth cancer, is a malignancy that develops in any part of the oral cavity. Oral cancer can occur on the lips, tongue, gums, cheek, and mucosa of the palate. Oral cancer therapy includes chemotherapy and radiotherapy which can cause side effects, one of them is oral mucositis. Oral mucositis is one of the most common complications of cancer therapy. The main complaint of patients with mucositis is pain which is characterized by clinical features in the form of an erythema, bleeding, and ulceration. Mouthwash has been widely used as an antimicrobial compound and topical prophylactic agent against oral mucositis. The purpose of this literature is to explain the differences between mouthwashes used and the one that produce a better therapeutic effect. Review: Mouthwash used to treat mucositis in several studies in the literature is saline, 0.12% chlorhexidine and 5% bicarbonate, and propolis. The results showed that the use of saline only provided moisture to the ulcerative area but did not suppress any pain. While the combination of 0.12% chlorhexidine and 5% bicarbonate has a healing effect for five to seven days. The propolis mouthwash has a healing effect for 14 days but only for adult patients. Conclusion: The study of mouthwash had many advantages and disadvantages against oral mucositis, but the mouthwash with a combination of 0.12% chlorhexidine and 5% bicarbonate had a good analgesic effect for patient with oral cancer.
Keywords
Full Text:
PDF (Bahasa Indonesia)References
Hassona Y, Sawair F, Matarweh D, Abdalhamid A, Thweib D, Scully C. Oral Cancer Early Detection: What Do Patients Need to Know? J Cancer Educ. 2018;33(4):865–9
Yusuf HY, Sjamsudin E, Hardianto A, tantry maulana R. Counseling about evaluation of stress levels and giving curcumin as herbal materials in mouth cavity cancer patients in Jayamekar Village, Padalarang district, Bandung Barat district. J Pengabdi Kpd Masy. 2018;2(3):259–63.
Em S, Rk A, Am A, Ama A, Mulla Z, Ha I, et al. Prognostic Factors in Early Tongue Cancer: A Retrospective Review. 2020;(July):1–5.
Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions. Oral Oncol. 2003;39(2):91–100.
Falzone L, Lupo G, La Rosa GRM, Crimi S, Anfuso CD, Salemi R, et al. Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer. Cancers (Basel). 2019;11(5).
Hassona Y, Sawair F, Matarweh D, Abdalhamid A, Thweib D, Scully C. Oral Cancer Early Detection: What Do Patients Need to Know? J Cancer Educ. 2018;33(4):865–9.
Yusuf HY, Sjamsudin E, Hardianto A, tantry maulana R. Counseling about evaluation of stress levels and giving curcumin as herbal materials in mouth cavity cancer patients in jayamekar village, padalarang district, bandung barat district. J Pengabdi Kpd Masy. 2018;2(3):259–63.
Em S, Rk A, Am A, Ama A, Mulla Z, Ha I, et al. Prognostic Factors in Early Tongue Cancer : A Retrospective Review. 2020;(July):1–5.
Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients:
Unanswered questions. Oral Oncol. 2003;39(2):91–100.
Falzone L, Lupo G, La Rosa GRM, Crimi S, Anfuso CD, Salemi R, et al. Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer. Cancers (Basel). 2019;11(5).
Greenspann editors SJ. Textbook of Oral Cancer: Prevention, Diagnosis and Management - Saman Warnakulasuriya, John S. Greenspan - (2020) 452 pp., ISBN: 978-3-030-32316-5. 2020.
Carole Fakhry, Karen T.Pitman, Ana P.Kiess DWE. Teks Book Oral Cancer - Evaluation, Therapy and Rehabilitation. 2019. 6–8 p.
Van Sebille YZA, Stansborough R, Wardill HR, Bateman E, Gibson RJ, Keefe DM. Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics. Curr Oncol Rep. 2015;17(11).
Raber-Durlacher JE, Elad S, Barasch A. Oral mucositis. Oral Oncol [Internet]. 2010;46(6):452–6. Available from: http://dx.doi.org/10.1016/j.oraloncology.2010.03.012
Napenas JJ, Shetty K V., Streckfus CF. Oral mucositis: Review of pathogenesis, diagnosis, prevention, and management. Gen Dent. 2007;55(4):335–44.
Vanhoecke B, De Ryck T, Stringer A, Van de Wiele T, Keefe D. Microbiota and their role in the pathogenesis of oral mucositis. Oral Dis. 2015;21(1):17–30.
FARLEY RH. A biological approach to therapeutics. Hahnemannian. 1953;88(1):23–4.
Lalla R V., Sonis ST, Peterson DE. Management of Oral Mucositis in Patients Who Have Cancer. Dent Clin North Am. 2008;52(1):61–77.
Cawley MM, Benson LM. Current trends in managing oral mucositis. Clin J Oncol Nurs. 2005;9(5):584–92.
Bowen J, Al-Dasooqi N, Bossi P, Wardill H, Van Sebille Y, Al-Azri A, et al. The pathogenesis of mucositis: updated perspectives and emerging targets. Support Care Cancer. 2019;27(10):4023–33.
Al-Dasooqi N, Gibson RJ, Bowen JM, Keefe DM. Matrix metalloproteinases: Key regulators in the pathogenesis of chemotherapy-induced mucositis? Cancer Chemother Pharmacol. 2009;64(1):1–9.
Sonis ST. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol [Internet]. 2009;45(12):1015–20. Available from:http://dx.doi.org/10.1016/j.oraloncology.2009.08.006
Rostini, Intang A, Darwis. Pengaruh penggunaan larutan nacl 0,9% terhadap lama hari rawat pada pasien vulnus laceratum di rumah sakit umum daerah h. andi sulthan daeng radja kabupaten bulukumba. Ilm Kesehat diagnosis [Internet]. 2013;2(4):1–6. Available from: http://ejournal.stikesnh.ac.id/index.php/jikd/article/view/451
Blumberg N, Cholette JM, Pietropaoli AP, Phipps R, Spinelli SL, Eaton MP, et al. 0.9% NaCl (Normal Saline) – Perhaps not so normal after all? Transfus Apher Sci [Internet]. 2018;57(1):127–31. Available from: https://doi.org/10.1016/j.transci.2018.02.021
Toxic SSS, Necrolysis E, Ilmu D, Anak K. Penanganan luka pada.
Mutluay Yayla E, Izgu N, Ozdemir L, Aslan Erdem S, Kartal M. Sage tea-thyme-peppermint hydrosol oral rinse reduces chemotherapy-induced oral mucositis: A randomized controlled pilot study. Complement Ther Med [Internet]. 2016;27:58–64. Available from: http://dx.doi.org/10.1016/j.ctim.2016.05.010
Maria OM, Eliopoulos N, Muanza T. Radiation-Induced Oral Mucositis. Front Oncol. 2017;7(MAY).
Hong CHL, Gueiros LA, Fulton JS, Cheng KKF, Kandwal A, Galiti D, et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019;27(10):3949–67.
Bachok N, Biswal BM, Razak NHA, Zainoon WMNW, Mokhtar K, Rahman RA, et al. Preliminary comparative study of oral7 ® versus salt-soda mouthwash on oral health related problems and quality of life among head and neck cancer patients undergoing radiotherapy. Malaysian J Med Sci. 2018;25(5):79–87.
Lalla R V., Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453–61.
Babadi F, Akbarnezhad M, Amin M, Saebi K. Effect of Jaftex and Chlorhexidine Mouthwashes on Oral Microorganism : A Comparative Study.
Hussain SA, Mohammed Ameen HA, Mohammed MO, Ahmed KM, Hama-Gareb Ali R, Safar BM, et al. Nigella sativa Oil
Mouth Rinse Improves Chemotherapy-Induced Oral Mucositis in Patients with Acute Myeloid Leukemia. Biomed Res Int. 2019;2019.
Choi SE, Kim HS. Natrium bicarbonate solution versus chlorhexidine mouthwash in oral care of acute leukemia patients undergoing induction chemotherapy: A randomized controlled trial. Asian Nurs Res (Korean Soc Nurs Sci) [Internet]. 2012;6(2):60–6. Available from: http://dx.doi.org/10.1016/j.anr.2012.05.004
Huang BS, Wu SC, Lin CY, Fan KH, Chang JTC, Chen SC. The effectiveness of a saline mouth rinse regimen and education programme on radiation-induced oral mucositis and quality of life in oral cavity cancer patients: A randomised controlled trial. Eur J Cancer Care (Engl). 2018;27(2):1–10.
Chan A, Ignoffo RJ. Survey of topical oral solutions for the treatment of chemo-induced oral mucositis. J Oncol Pharm Pract. 2005;11(4):139–43.
Cabrera-Jaime S, Martínez C, Ferro-García T, Giner-Boya P, Icart-Isern T, Estrada-Masllorens JM, et al. Efficacy of Plantago major, chlorhexidine 0.12% and Natrium bicarbonate 5% solution in the treatment of oral mucositis in cancer patients with solid tumour: A feasibility randomised triple-blind phase III clinical trial. Eur J Oncol Nurs [Internet]. 2018 ;32 (November 2017) : 40 – 7. Available from: https://doi.org/10.1016/j.ejon.2017.11.006
Sung SH, Choi GH, Lee NW, Shin BC. External Use of Propolis for Oral, Skin, and Genital Diseases: A Systematic Review and Meta-Analysis. Evidence-based Complement Altern Med. 2017;2017.
Piredda M, Facchinetti G, Biagioli V, Giannarelli D, Armento G, Tonini G, et al. Propolis in the prevention of oral mucositis in breast cancer patients receiving adjuvant chemotherapy: A pilot randomised controlled trial. Eur J Cancer Care (Engl). 2017;26(6):1–8.
VRAS N, EN A, FPCL P, VR S. Propolis gel versus benzydamine in preventing oral mucositis for patients irradiated in head and neck: a preliminary study. Cancer Reports Rev. 2017;1(2).
Martins ML, Monteiro ASN, Guimarães JEC, Guimarães MB de CT, da Silva RF, Cabral LM, et al. Cytotoxic and antibacterial effect of a red propolis mouthwash, with or without fluoride, on the growth of a cariogenic biofilm. Arch Oral Biol [Internet].2019;107(January):104512. Available from: https://doi.org/10.1016/j.archoralbio.2019.104512
Sabanović M, Saltović S, Mujkić AA, Jašić M, Bahić Z. Impact of Propolis on the Oral Health. Balk J Dent Med. 2019;23(1):1–9.
Liu TM, Luo YW, Tam KW, Lin CC, Huang TW. Prophylactic and therapeutic effects of honey on radiochemotherapy-induced mucositis: a meta-analysis of randomized controlled trials. Support Care Cancer. 2019;
Kripal K, SM M, SM S, Kumar SM D, SM SS, Bhavanam SR, et al. Health from the Hive: 5% Propolis Mouth Wash as an Adjunct in the Treatment of Chronic Generalized Gingivitis-A Randomized Controlled Clinical Trial. Dentistry. 2019;09(01):0–6.
Nazeri R, Ghaiour M, Abbasi S. Evaluation of Antibacterial Effect of Propolis and Its Application in Mouthwash Production. Front Dent. 2019;1–12.
Crisan I, Zaharia CN, Popovici F, Jucu V, Belu O, Dascalu C, Mutiu A PA. NATURAL HEALTH PRODUCT PROPOLIS Oral This. Heal CANADA. 2016;52(10):1176–84.
Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patient with cancer. Dent Clin North Am. 2008;52:61-viii.
Bowen JM, Elad S, Hutchins RD, Lalla RV. Mucositis study group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO. Methodology for the MASCC/ISOO mucositis clinical practice guidelines update). Support Care Cancer. 2013;21:303-8.
Al-Ansari S, Zecha JA, Barasch A, de Lange J, Rozema FR, Raber-Durlacher JE. Oral mucositis induced by anticancer therapies. Curr Oral Health Rep. 2015;2(4):202-11.
Subramaniam P, Babu KL, Nagarathna J. Oral manifestations in acute lymphoblastic leukemic children under chemotherapy. J Clin Pediatr Dent. 2008;32:319-24.
Girish Babu KL, Mathew J, Doddamani GM, Narasimhaiah JK, Naik LR. Oral health of children with acute lymphoblastic leukemia: A review. J Orofac Sci. 2016;8:3-11.
DOI: https://doi.org/10.33854/jbd.v9i1.1020
DOI (PDF (Bahasa Indonesia)): https://doi.org/10.33854/jbd.v9i1.1020.g414
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 B-Dent: Jurnal Kedokteran Gigi Universitas Baiturrahmah
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.